International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Patient Access Is a Patient Safety Issue

Author(s): Pore David

Issue: Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Page(s): 120-121

Patient Access Is a Patient Safety Issue Page 1

Patient Access Is a Patient Safety Issue Page 2

Download in electronic PDF format for $75

Abstract: The International Academy of Compounding Pharmacists comments on the regulations of the compounding profession, patient access to compounded medications, and the importance of patient safety.

Related Keywords: International Academy of Compounding Pharmacists, IACP, US Food and Drug Administration, FDA, pharmacy laws, pharmacy regulations, drug safety

Related Categories: LEGAL

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Patient Access Is a Patient Safety Issue Pore David	Mar/Apr 2019 Pg. 120-121
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G	May/Jun 2014 Pg. 208
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William	Nov/Dec 2020 Pg. 451-458
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Miller David G	Sep/Oct 2015 Pg. 375
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations McCrory Gary	Mar/Apr 2016 Pg. 95-96
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Mixon Bill, Nain John	May/Jun 2013 Pg. 182-190
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Miller David G	Mar/Apr 2014 Pg. 117-118
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Miller David G	Nov/Dec 2015 Pg. 449-450
The International Academy of Compounding Pharmacists Introduces a New President Rice Baylor	Mar/Apr 2017 Pg. 116-117
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
Return to Top